146
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Variation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry

, ORCID Icon, , , , , , , , ORCID Icon, , ORCID Icon, , ORCID Icon, , , ORCID Icon, , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 17-31 | Published online: 29 Apr 2022

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 report. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed April 20, 2021.
  • World Health Organization. Burden of COPD. Available from: https://www.who.int/respiratory/copd/burden/en/. Accessed December 2, 2020.
  • National Center for Health Statistics. Health, United States. In: Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Hyattsville (MD): National Center for Health Statistics (US); 2016.
  • Centers for Disease Control and Prevention. Leading causes of death. Available from: https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm. Accessed December 2, 2020.
  • Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-0972
  • May SM, Li JT. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy Asthma Proc. 2015;36(1):4–10. doi:10.2500/aap.2015.36.3812
  • Huybrechts KF, Bateman BT, Pawar A, et al. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: Cohort Study. BMJ;2020. m237. doi:10.1136/bmj.m237
  • Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. Can Med Assoc J. 2010;182(7):673–678. doi:10.1503/cmaj.091784
  • Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. COPD screening efforts in primary care: what is the yield? Prim Care Respir J. 2007;16(1):41–48. doi:10.3132/pcrj.2007.00009
  • Johns DP, Walters JAE, Walters EH. Diagnosis and early detection of COPD using spirometry. J Thorac Dis. 2014;6(11):1557–1569. doi:10.3978/j.issn.2072-1439.2014.08.18
  • Albitar HAH, Iyer VN. Adherence to Global Initiative for Chronic Obstructive Lung Disease guidelines in the real world: current understanding, barriers, and solutions. Curr Opin Pulm Med. 2020;26(2):149–154. doi:10.1097/MCP.0000000000000655
  • van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J. 2003;21(Supplement 39):16S–22S. doi:10.1183/09031936.03.00040403
  • Jones RCM, Price D, Ryan D, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014;2(4):267–276. doi:10.1016/S2213-2600(14)70008-6
  • Calverley PM. COPD: early detection and intervention. Chest. 2000;117(5 Suppl 2):365s–371s. doi:10.1378/chest.117.5_suppl_2.365S
  • Larsson K, Janson C, Ställberg B, et al. Impact of COPD diagnosis timing on clinical and economic outcomes: the Arctic Observational Cohort Study. Int J Chron Obstruct Pulmon Dis. 2019;14:995–1008. doi:10.2147/COPD.S195382
  • Ferrone M, Masciantonio MG, Malus N, et al. The impact of integrated disease management in high-risk COPD patients in primary care. NPJ Prim Care Respir Med. 2019;29(1):8. doi:10.1038/s41533-019-0119-9
  • Rennard S, Thomashow B, Crapo J, et al. Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation. COPD. 2013;10(3):378–389. doi:10.3109/15412555.2013.801309
  • Yawn BB, Thomashaw B, Mannino DM, et al. The 2017 update to the COPD Foundation COPD pocket consultant guide. COPD. 2017;4(3):177–185. doi:10.15326/jcopdf.4.3.2017.0136
  • Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–191. doi:10.7326/0003-4819-155-3-201108020-00008
  • Criner GJ, Bourbeau J, Diekemper RL, et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015;147(4):894–942. doi:10.1378/chest.14-1676
  • Department of Defense, D. of V. A. VA/DoD. Clinical practice guideline for the management of Chronic Obstructive Pulmonary Disease; 2014. Available from: https://www.healthquality.va.gov/guidelines/CD/copd/VADoDCOPDCPG.pdf. Accessed December 2, 2020.
  • Ridic G, Gleason S, Ridic O. Comparisons of health care systems in the United States, Germany and Canada. Mater Sociomed. 2012;24(2):112–120. doi:10.5455/msm.2012.24.112-120
  • Agency for Healthcare Research and Quality. 2018 national healthcare quality and disparities report. Available from: https://www.ahrq.gov/research/findings/nhqrdr/nhqdr18/index.html. Accessed December 2, 2020.
  • Edwards CL, Kaplan AG, Yawn BP, et al. Development of the advancing the patient experience in COPD registry: a Modified Delphi Study. COPD. 2021;8(1):135–151. doi:10.15326/jcopdf.2020.0154
  • Halpin DMG, de Jong HJI, Carter V, Skinner D, Price D. Distribution, temporal stability and appropriateness of therapy of patients with COPD in the UK in relation to GOLD 2019. EClinicalMedicine. 2019;14:32–41. doi:10.1016/j.eclinm.2019.07.003
  • Gilkes A, Ashworth M, Schofield P, et al. Does COPD risk vary by ethnicity? A retrospective cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2016;11:739–746. doi:10.2147/COPD.S96391
  • Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–555. doi:10.1513/pats.200709-148ET
  • Wagena EJ, Knipschild PG, Huibers MJH, Wouters EFM, van Schayck CP. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with Chronic Obstructive Pulmonary Disease. Arch Intern Med. 2005;165(19):2286–2292. doi:10.1001/archinte.165.19.2286
  • Tønnesen P. Smoking cessation and COPD. Eur Respir Rev. 2013;22(127):37. doi:10.1183/09059180.00007212
  • Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MPMH. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax. 2010;65(8):711. doi:10.1136/thx.2009.131631
  • Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev. 2008;17(6):535–544. doi:10.1097/CEJ.0b013e3282f75e48
  • Centers for Disease Control and Prevention. Coverage for Tobacco use cessation treatments. Content last reviewed on June 2, 2021. Available from: https://www.cdc.gov/tobacco/quit_smoking/cessation/coverage/index.htm. Accessed August 18, 2021.
  • Mohan A, Sethi S. The reliability and validity of patient-reported chronic obstructive pulmonary disease exacerbations. Curr Opin Pulm Med. 2014;20(2):146–152. doi:10.1097/MCP.0000000000000032
  • Mackay AJ, Kostikas K, Murray L, et al. Patient-reported outcomes for the detection, quantification, and evaluation of Chronic Obstructive Pulmonary Disease exacerbations. Am J Respir Crit Care Med. 2018;198(6):730–738. doi:10.1164/rccm.201712-2482CI
  • American Lung Association. My COPD action plan. Available from: https://www.lung.org/getmedia/c7657648-a30f-4465-af92-fc762411922e/fy20-ala-copd-action-plan.pdf. Accessed September 3, 2021.
  • Wells CD, Joo MJ. COPD and asthma: diagnostic accuracy requires spirometry. J Fam Pract. 2019;68(2):76–81.